Seòmar agus comataidhean

Convener, I should just place on the record that, earlier, I was listening to the meeting online, so I was able to hear the minister.

Thank you. Will you also be writing to and contacting everyone who had mesh implants in Scotland to highlight the scheme and say, “If you received your mesh here and are eligible because you’ve had private surgery to remove it, we will reimburse you.”? I did not see that as something that you are doing to promote the scheme.

I should first of all put it on the record that Dr Jamieson was the clinical supervisor for my own work.

I have a question for Dr Lamont about costs. I know that we are talking about reimbursement here, but what do you think the indicative costs will be for women going to the NHS, Spire Healthcare in Bristol or the United States?

Thank you for your response to the convener’s questions, but I would say that it is not an either/or issue. It would be nice if we could add to the list those women who had their mesh implanted here but who had to pay privately for the surgery to get it removed after they had moved away from Scotland. After all, it was the NHS in Scotland that implanted the mesh in the first place, and those women should be reimbursed for any out-of-pocket expenses. I understand from Greig Chalmers that you have not as yet been contacted by anyone in that respect, but even if reimbursement in those circumstances could help just one woman, it would be good for us to do it.

Would there be a difference between those who are directly employed and those who are—

I want to ask about the way that the money is used. My understanding is that a board gets its money through its funding, which is then divided into allocations. I always hear clinicians saying that they are not able to use that money, so who is the determiner of how that money is spent? Is it clinicians, or is it managers? Who do you feel it should be?

Can we start with David, please?

This is directed to Derek Feeley. In your summary, recommendation 17 says:

“Integration Joint Boards should manage GPs’ contractual arrangements, whether independent contractors or directly employed”.

Under that model—in the ideal vision that you have set out—would you want the general practitioner workforce to be directly employed or independent contractors ?

How would the IJB manage the contracts with independent contractors and those who are directly employed? What are the differences in that management?

My question is for Derek Feeley. In relation to IJBs, will there be a difference between those who are directly employed under the 2C contracts and independent contractors, or will things be done in much the same way?